Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jean Delgrande"'
Autor:
Pauline Podeur, Julien Mancini, Jean Delgrande, Laure Santini, Sébastien Salas, Stéphanie Wong, Antoine Giovanni, Patrick Dessi, Justin Michel, Thomas Radulesco, Nicolas Fakhry
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
PurposeTo evaluate the impact of tonsillectomy on the detection of the primary tumor, based on p16 immunohistochemistry analysis, in patients with cervical unknown primary of squamous cell carcinoma (SCC-CUP).MethodsThis was a retrospective study of
Externí odkaz:
https://doaj.org/article/d4a0cb4aad634ee4b2b1bf1a8c9ace2f
Autor:
Mehdi Ouaïssi, Françoise Silvy, Céline Loncle, Diva Ferraz da Silva, Carla Martins Abreu, Emmanuelle Martinez, Patrick Berthézene, Sophie Cadra, Yves Patrice Le Treut, Jean Hardwigsen, Bernard Sastre, Igor Sielezneff, Liliane Benkoel, Jean Delgrande, Ali Ouaissi, Juan Iovanna, Dominique Lombardo, Eric Mas
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108520 (2014)
Ductal adenocarcinoma of the pancreas is ranking 4 for patient' death from malignant disease in Western countries, with no satisfactory treatment. We re-examined more precisely the histone deacetylases (HDAC) and Sirtuin (SIRT) gene expression patter
Externí odkaz:
https://doaj.org/article/c00a39e0f609463f951403ad6dcef0e3
Autor:
Julien Mancini, Stéphanie Wong, Thomas Radulesco, Nicolas Fakhry, Laure Santini, Pauline Podeur, Jean Delgrande, Antoine Giovanni, Justin Michel, Patrick Dessi, Sébastien Salas
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Frontiers, 2020, 10, pp.594168. ⟨10.3389/fonc.2020.594168⟩
Frontiers in Oncology, 2020, 10, pp.594168. ⟨10.3389/fonc.2020.594168⟩
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Frontiers, 2020, 10, pp.594168. ⟨10.3389/fonc.2020.594168⟩
Frontiers in Oncology, 2020, 10, pp.594168. ⟨10.3389/fonc.2020.594168⟩
Frontiers in Oncology, Vol 10 (2020)
International audience; Purpose: To evaluate the impact of tonsillectomy on the detection of the primary tumor, based on p16 immunohistochemistry analysis, in patients with cervical unknown primary of squamous cell carcinoma (SCC-CUP).Methods: This w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda5904e301a0b06c779e09f563972ab
https://www.hal.inserm.fr/inserm-03106191/document
https://www.hal.inserm.fr/inserm-03106191/document
Autor:
Claire Mallaret, Julien Mancini, Emilie Nouguered, Laetitia Dahan, Jean Francois Seitz, Vincent Moutardier, Mehdi Ouaissi, Xavier Edouard Truchet, Véronique Secq, Stéphane Garcia, J. Ciccolini, Mohamed Gasmi, Jean Delgrande, Marion Rubis, Yves Patrice Le Treut, Marie-Noëlle Lavaut
Publikováno v:
Journal of Clinical Oncology. 32:e15191-e15191
e15191 Background: Since 2005, adjuvant chemotherapy with gemcitabine (Gem) or 5fluorouracil (5FU) plus folinic acid for 6 months is a standard in resected pancreatic cancer. Predictive factors of ...